Announcements
- Calian to Hold Conference Call Following Announcement of Second Quarter FY 2024 Results
- Calian tiendra une conférence téléphonique après l’annonce des résultats du deuxième trimestre de l’exercice 2024
- Calian Secures Contract Valued up to $90M for IT and Software Development Services with General Dynamics Mission Systems– Canada to Support Canadian Army
- Calian Wins $23 Million Contract for New Military Medical Training Program with the Canadian Armed Forces
- Calian Announces the Appointment of New President of Advanced Technologies
- Calian to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency
- Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuclear Assets
- Calian renforce sa capacité nucléaire avec l’acquisition des actifs nucléaires de MDA Ltd.
- Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate
- Calian remporte un contrat pour soutenir l’essai clinique du principal médicament candidat de ZYUS Life Sciences
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 11.85m |
Free float | 11.78m |
P/E (TTM) | 32.29 |
Market cap | 638.93m CAD |
EPS (TTM) | 1.68 CAD |
Annual div (ADY) | 0.7634 EUR |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 27 2024 |
Div pay-date | Mar 13 2024 |
Data delayed at least 15 minutes.
More ▼